Current Price | $762.66 | Mkt Cap | $725.1B |
---|---|---|---|
Open | $762.28 | P/E Ratio | 134.16 |
Prev. Close | $762.66 | Div. (Yield) | $4.69 (0.6%) |
Daily Range | $758.25 - $769.68 | Volume | 2,521,351 |
52-Wk Range | $323.26 - $800.78 | Avg. Daily Vol. | 3,197,590 |
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
Current Price | $762.66 | Mkt Cap | $725.1B |
---|---|---|---|
Open | $762.28 | P/E Ratio | 134.16 |
Prev. Close | $762.66 | Div. (Yield) | $4.69 (0.6%) |
Daily Range | $758.25 - $769.68 | Volume | 2,521,351 |
52-Wk Range | $323.26 - $800.78 | Avg. Daily Vol. | 3,197,590 |
The best Bull and Bear pitches based on recency and number of recommendations.
Eli Lilly's top-notch diabetes drug portfolio led by Trulicity, as well as its plaque psoriasis and psoriatic arthritis blockbuster Taltz should lead to mid-teen annual earnings growth in the foreseeable future. While Eli Lilly isn't a bargain buy at… More
Read the most recent pitches from players about LLY.
Recs
S&P Growing Dividend
Payout Ratio Under 50%
Ranking high in EY (EBIT/EV) and GPA
Reasonably priced when checked against some baseline valuation checks.
EBIT/Investment: 31%
Proj EPS Growth: 50%
Recs
massive market for obesity and weight loss - recurring revenue - early innings still
Recs
https://www.luf.org
Find the members with the highest scoring picks in LLY.
tektan (89.09) Score: +3,552.66
The Score Leader is the player with the highest score across all their picks in LLY.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
MarketPwnage | 78.98 | 3/9/2009 | NS | $17.65 | +4,220.51% | +667.84% | +3,552.66 | 0 Comment | ||
tektan | 89.09 | 3/9/2009 | 5Y | $17.65 | +4,220.51% | +667.84% | +3,552.66 | 0 Comment | ||
MCMInvest | 72.60 | 3/9/2009 | NS | $17.65 | +4,220.51% | +667.84% | +3,552.66 | 0 Comment | ||
thomasgb | 48.13 | 3/4/2009 | 3Y | $17.81 | +4,183.28% | +631.85% | +3,551.43 | 0 Comment | ||
LordCoolio | 62.68 | 3/2/2009 | 3M | $18.17 | +4,096.32% | +619.74% | +3,476.58 | 0 Comment | ||
fredericch | 97.17 | 3/2/2009 | NS | $18.17 | +4,096.32% | +619.74% | +3,476.58 | 0 Comment | ||
sunsluv72 | 89.47 | 3/12/2009 | 3Y | $18.37 | +4,052.75% | +618.69% | +3,434.05 | 0 Comment | ||
Zhire | 64.46 | 3/10/2009 | 5Y | $18.23 | +4,084.58% | +650.83% | +3,433.75 | 0 Comment | ||
eyeseeu2 | 95.73 | 11/21/2008 | NS | $18.55 | +4,012.17% | +579.35% | +3,432.82 | 0 Comment | ||
harryhotspur1403 | 67.44 |
|
1Y | $19.00 | +3,913.85% | +506.06% | +3,407.80 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.